Makers of Ozempic, Mounjaro race to meet demand for weight-loss drugs - The Washington Post
washingtonpost.comSubmitted by thewashingtonpost7104 in business
Novo Nordisk and Eli Lilly are going to extraordinary lengths to secure the plants and machinery needed to churn out their popular appetite-suppressing drugs.